Wells Fargo & Company Genocea Biosciences, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GNCA
# of Institutions
1Shares Held
10KCall Options Held
0Put Options Held
0About GENOCEA BIOSCIENCES, INC.
- Ticker GNCA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,783,500
- Description
- Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...